drugset / Trial / NCT02688270
Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine the ability of Vascana (0.9% nitroglycerin topical cream) to treat and prevent the symptoms experienced by subject's with Raynaud's Phenomenon. The symptoms of this disease include pain, tingling, and numbness in the fingers of the affected hand or hands.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitroglycerin | Unknown | 0.9 % | Topical |